Drinking from the fountain of promise: biomarkers in the surveillance of Barrett's oesophagus--the glass is half full!
Preston
S L
SL
Department of Gastroenterology, Concord Repatriation General Hospital, Sydney, Australia, and Histopathology Unit, Cancer Research UK, London, UK.
Jankowski
J A
JA
D001471:Barrett Esophagus / Q000175:diagnosis*; D014408:Biomarkers, Tumor / Q000378:metabolism*; D004938:Esophageal Neoplasms / Q000175:diagnosis*; D006801:Humans; D011379:Prognosis; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism
D014408:Biomarkers, Tumor; D016159:Tumor Suppressor Protein p53